DUALITYBIO-B (09606): Hua Haiqing appointed as an executive director of the company.
Ening Biology-B (09606) announced that from March 23, 2026: (1) Ms. Si Wen resigned as an executive director of the company and a member of the compensation committee; (2) Dr. Hua Haiqing was appointed as an executive director of the company; (3) Mr. Zhang Shaoren was appointed as the company's Chief Financial Officer; (4) Dr. Zhu Zhongyuan was appointed as a member of the company's compensation committee.
DUALITYBIO-B (09606) announcement: Starting from March 23, 2026, (1) Ms. Si Wen resigns as the company's executive director and member of the Compensation Committee; (2) Dr. Huaha Qing is appointed as the company's executive director; (3) Mr. Zhang Shaoren is appointed as the company's Chief Financial Officer; (4) Dr. Zhu Zhongyuan is appointed as a member of the company's Compensation Committee.
Related Articles
WELL LINK SEC (08350) announces earnings joy, expecting a net profit of not less than 50 million Hong Kong dollars for the fiscal year 2025, turning losses into profits year-on-year.
HEVOL SERVICES (06093) issued a profit warning, expecting an annual net loss attributable to shareholders of the company of 57 million to 67 million yuan, a year-on-year change from profit to loss.
INTL GENIUS (00033) appoints Zhao Yan as the chairman of the compensation committee.
WELL LINK SEC (08350) announces earnings joy, expecting a net profit of not less than 50 million Hong Kong dollars for the fiscal year 2025, turning losses into profits year-on-year.
HEVOL SERVICES (06093) issued a profit warning, expecting an annual net loss attributable to shareholders of the company of 57 million to 67 million yuan, a year-on-year change from profit to loss.
INTL GENIUS (00033) appoints Zhao Yan as the chairman of the compensation committee.
